AM – Upcoming Webinars
Alpha-mannosidosis is ultra-rare, but its impact is profound. Delays in diagnosis are all too common, caused by the broad variability of symptoms and their similarity to other pediatric conditions. The AM Learning Zone helps healthcare professionals think rare, recognise early signs, and act faster—transforming outcomes with earlier, more accurate referrals and care.
Behind every learning session is a team of passionate clinicians, researchers, and educators committed to early intervention in Alpha-mannosidosis.
The THINK RARE program is independently developed and managed by EIP with respect to content, topics, and appointed speakers. Unrestricted grants are sought to support EIP's activities; Chiesi Farmaceutici S.p.A. has provided an unrestricted grant to partially support EIP's work on the early diagnosis of metabolic disorders.
.webp)
